Werewolf Therapeutics HOWL
NASDAQ HOWL
$0.87 +0.44 (+102.57%)
At close: Aug 21, 2026 · 4:00 PM EDT

Werewolf Therapeutics (HOWL) Amortizatization of Intangibles (2020 - 2021)

Werewolf Therapeutics (HOWL) posted quarterly Amortizatization of Intangibles of $56.9 million for Q2 2021, up 183532.26% year-over-year from N/an in Q2 2020, and down 40.09% on a QoQ basis from $95.0 million in Q1 2021.

Werewolf Therapeutics (HOWL) Amortizatization of Intangibles (2020 - 2021) Analysis & Trends

Werewolf Therapeutics has reported Amortizatization of Intangibles for 2 years, with the latest figure at $56.9 million in Q2 2021.

  • Amortizatization of Intangibles for Q2 2021 came in at $56.9 million, up 183532.26% year-over-year; the trailing twelve-month figure through Mar 2022 was $56.9 million (down 47.38% YoY), and the FY2021 annual result was $151.9 million, up 1053.08% from the prior year.
  • Amortizatization of Intangibles retreated to $56.9 million in Q2 2021, from $95.0 million in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $95.0 million in Q1 2021 and troughed at $31000.0 in Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 678,000.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Werewolf Therapeutics 43.94 Mn 43.94 Mn - 89,000.00

Historic Data

Download Data
DateValue
Jun 30, 2021 56.93 Mn
Jun 30, 2021 56.93 Mn
Mar 31, 2021 95.02 Mn
Mar 31, 2021 95.02 Mn
Dec 31, 2020 13.15 Mn
Dec 31, 2020 13.15 Mn
Jun 30, 2020 31,000.00
Jun 30, 2020 31,000.00